Skip to content

Live event

Detected Nov 17, 04:07 ETNVSRegulation · Approval or legal win

Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)

manilatimes.net

What similar events did
Leans downweak71 of 132 similar events trailed the market
What happened
+1.28%vs the market · stock +0.44%Went against the lean

The lean describes how earlier events of the same kind moved after ShockSense detected them; it is recorded at detection and never changed. The move runs from the first tradable price after detection to the close that ends the event's window, measured against the market. Methodology

Alerts for the sectors and news types you choose, and a daily digest after the close, on Telegram or email.

Historical market-reaction analytics for research and educational purposes. Not investment advice. All latest events

Share card for this NVS event
NVS: Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people… — ShockSense